ABEO MENU

About ABEO

PlasmaTech Biopharmaceuticals is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. PlasmaTech's lead program is a gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. In addition, the company is pursuing two additional proprietary platforms, Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT), and is active in the development and commercialization of human plasma-derived therapeutics, including its proprietary alpha-1 protease inhibitor, SDF Alpha. The company has developed a robust product pipeline that includes two commercial stage products, MuGard and ProctiGard, with additional follow-on products in development.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ABEO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 97.1 M 9.705E+07 1,992 1992 0.0% 1.25071E-05 4 K 3836
UWM ProShares Ultra Russell2000 191.6 M 1.91595E+08 1,991 1991 0.0% 1.86365E-05 8 K 7684
ITOT iShares Core S&P Total U.S. Stock Market ETF 24.3 B 2.43148E+10 3,553 3553 0.0% 0 65 K 65374
IWC iShares Microcap ETF 831.4 M 8.31356E+08 1,383 1383 0.03% 0.0003 252 K 252239
IWM iShares Russell 2000 ETF 46.1 B 4.60786E+10 1,981 1981 0.01% 0.0001 2.4 M 2427820
IWN iShares Russell 2000 Value ETF 9.5 B 9.53317E+09 1,380 1380 0.01% 0.0001 977 K 976872
IWV iShares Russell 3000 ETF 9.9 B 9.87999E+09 2,886 2886 0.0% 0 24 K 24219
IEIH iShares Evolved U.S. Innovative Healthcare ETF 5.5 M 5532190 217 217 0.01% 0.0001 407 407
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.5 B 1.48129E+09 2,223 2223 0.0% 1.6E-05 24 K 23549
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.0% 8.18217E-07 2 K 1739